Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Submitted by
admin
on July 26, 2017 - 10:33pm
Source:
Fierce Pharma
News Tags:
Eli Lilly
baricitinib
Pfizer
Xeljanz
bloodthinners
Headline:
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Do Not Allow Advertisers to Use My Personal information
